Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial

BACKGROUND: Major Depressive Disorder (MDD) has been associated with brain-related changes. However, biomarkers have yet to be defined that could “accurately” identify antidepressant-responsive patterns and reduce the trial-and-error process in treatment selection. Cerebral blood perfusion, as measu...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:EClinicalMedicine
Main Authors: Cooper, Crystal M., Chin Fatt, Cherise R., Jha, Manish, Fonzo, Gregory A., Grannemann, Bruce D., Carmody, Thomas, Ali, Aasia, Aslan, Sina, Almeida, Jorge R.C., Deckersbach, Thilo, Fava, Maurizio, Kurian, Benji T., McGrath, Patrick J., McInnis, Melvin, Parsey, Ramin V., Weissman, Myrna, Phillips, Mary L., Lu, Hanzhang, Etkin, Amit, Trivedi, Madhukar H.
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier 2019
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6543260/
https://ncbi.nlm.nih.gov/pubmed/31193824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.04.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares